Contact us

Do you have a product with potential for the Republic of Moldova? Discuss an opportunity with TOP-PHARMA.

Contact details

Address
Str. Alessandro Bernardazzi 78, Chișinău, MD-2009
Email
info@toppharm.md
Phone
+373 22 24 11 26

Pharmacovigilance

To report an adverse reaction, please use the dedicated page.

Report an adverse reaction

Discuss an opportunity with TOP-PHARMA

We are ready to assess the opportunity and discuss the local registration, launch, promotion and commercial development strategy for your product.

Fields marked * are required.

Google Maps uses cookies. The map is shown once you accept functional cookies, or if you load it now.

Why TOP-PHARMA?

Because choosing a local partner means more than choosing a distributor.

At TOP-PHARMA you will find, within a single organisation, regulatory expertise, our own GDP infrastructure, pharmacovigilance, pharmaceutical marketing, a team of medical representatives and commercial relationships built over more than two decades of activity in the Republic of Moldova.

We understand the local specifics and take ownership of developing our partners' products with a long-term perspective.

What we look for
  • Reputable pharmaceutical manufacturers with strong quality standards
  • Medicines and healthcare products addressing relevant patient and healthcare needs
  • Products with differentiated positioning and sustainable commercial potential
  • An appropriate balance between quality and patient accessibility
  • Partners interested in building a sustainable, long-term presence in Moldova

How a collaboration starts

  1. 01

    First contact

    You send us the product information through the form above or directly by e-mail.

  2. 02

    Assessment

    We review regulatory feasibility, the therapeutic context and the commercial potential for the local market.

  3. 03

    Proposal

    We come back with an honest assessment and, if the opportunity is there, a proposed collaboration model.

  4. 04

    Contracting and launch

    We agree the contractual framework, including the pharmacovigilance agreement, and start the registration process.